These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25331811)

  • 21. Revisiting the commercial-academic interface.
    Drazen JM
    N Engl J Med; 2015 May; 372(19):1853-4. PubMed ID: 25946285
    [No Abstract]   [Full Text] [Related]  

  • 22. Australian experience of trying to increase transparency between doctors and industry.
    Dalton B
    BMJ; 2014 Feb; 348():g1385. PubMed ID: 24500364
    [No Abstract]   [Full Text] [Related]  

  • 23. Responses to peer commentaries on "Clarifying conflict of interest".
    Brody H
    Am J Bioeth; 2011 Jan; 11(1):W4-5. PubMed ID: 21240796
    [No Abstract]   [Full Text] [Related]  

  • 24. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

  • 25. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distributions of industry payments to Massachusetts physicians.
    Kesselheim AS; Robertson CT; Siri K; Batra P; Franklin JM
    N Engl J Med; 2013 May; 368(22):2049-52. PubMed ID: 23635021
    [No Abstract]   [Full Text] [Related]  

  • 27. US Senate committee investigates conflicts of interest in industry funded medical education.
    Tanne JH
    BMJ; 2009 Aug; 339():b3139. PubMed ID: 19654162
    [No Abstract]   [Full Text] [Related]  

  • 28. Answering Brody's challenge from a pharmapologist perspective.
    Harter TD
    Am J Bioeth; 2011 Jan; 11(1):29-30. PubMed ID: 21240803
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ethics and Transparency Committee on the Relationship Physician-Industry (CETREMI); suggestions to doctors in their relations with pharmaceutical industry].
    Lifshitz A; Halabe J; Jasso L; Frati A; Alva C; Arrieta Ó; Burgos R; Campillo C; Celis MÁ; de la Llata M; Domínguez J; Islas R; Moreno M; Plancarte R; Reyes A; Soda A; Verástegui E; Sotelo J
    Gac Med Mex; 2016; 152(3):295-6. PubMed ID: 27335182
    [No Abstract]   [Full Text] [Related]  

  • 30. Industry has undue influence on academic collaboration and safeguards need strengthening: white coat… which hat.
    Harbin T
    Surv Ophthalmol; 2014; 59(3):346-8. PubMed ID: 24508214
    [No Abstract]   [Full Text] [Related]  

  • 31. [Physicians and the drug industry. "To be like that, you'd better be married."].
    Peiró S
    Rev Calid Asist; 2009 Apr; 24(2):47-50. PubMed ID: 19426926
    [No Abstract]   [Full Text] [Related]  

  • 32. Clarifying conflict of interest.
    Brody H
    Am J Bioeth; 2011 Jan; 11(1):23-8. PubMed ID: 21240802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doctor takes "march of shame" to atone for drug company payments.
    Lenzer J; Brownlee S
    BMJ; 2008 Jan; 336(7634):20-1. PubMed ID: 18174595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dos and don'ts of collaborating with industry.
    Moynihan R
    BMJ; 2012 May; 344():e3247. PubMed ID: 22569871
    [No Abstract]   [Full Text] [Related]  

  • 35. Is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive? - No.
    Bhattacharyya S; Burns A
    Int Psychogeriatr; 2007 Dec; 19(6):1010-4; discussion 1014-20. PubMed ID: 17711609
    [No Abstract]   [Full Text] [Related]  

  • 36. Physicians and the pharmaceutical industry: working together on conflict of interest.
    Kitsis EA
    Am J Bioeth; 2011 Jan; 11(1):51-2. PubMed ID: 21240814
    [No Abstract]   [Full Text] [Related]  

  • 37. IOM warns about physician-pharma conflicts of interest.
    Landers SJ; O'Reilly KB
    Del Med J; 2009 Jul; 81(7):261-3. PubMed ID: 19902777
    [No Abstract]   [Full Text] [Related]  

  • 38. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 39. Money for drugs: should physicians be paid for pharmaceutical development and clinical investigations?
    Van Way CW; Bohigian G
    Mo Med; 2011; 108(6):414. PubMed ID: 22338732
    [No Abstract]   [Full Text] [Related]  

  • 40. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia.
    Wilson A
    Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.